Strategic partnership with leading physical exam, pharmaceutical, imaging, and senior housing enterprises in China

Dr. Brain rolls out physical exam and disease screening services for early intervention and accurate diagnosis of CNS diseases, and joins hands with an insurance institution to launch Cognitive Deterioration Guarantee Plan, the first in China to allow claim filing based on AI diagnostic technology, building an integrated service platform for the diagnosis, treatment, rehabilitation and insurance of CNS diseases in collaboration with up-, mid-, and down-stream service providers.

Partners

Business partners

Beijing Beilu Pharmaceutical Co., Ltd.

As the first listed enterprise in China that has established a strategic layout in the field of precision medicine, Beilu Pharm is the exclusive investor of Dr. Brain in its series-A funding. Both companies have demonstrated strong synergies in the areas of medical imaging and central nervous system. Dr. Brain will join Beilu Pharm’s collaborative programs in all aspects and participate in the next phase of its new strategic drug development, contributing to the diagnosis, treatment, and prevention of central nervous system diseases.

Haier Group

Founded in 1984, Haier Group is the world's No. 1 brand of major home appliances and has topped the Most Valuable Chinese Brands ranking list for 11 consecutive years, with more than 70,000 employees. In 2018, Haier Capital, a subsidiary of Haier Group, became a shareholder of Dr. Brain, joining its efforts to explore the new field of intelligent medicine and spearhead brain disease prevention and treatment in China.

Rimag Imaging Hospital Group

Dr. Brain and Rimag have fulfilled an in-depth strategic cooperation to build a demonstration center for AI-based brain health examination, to reach more grassroots users with more accurate and efficient AI technology, and to connect with medical institutions at all levels, physical exam centers, and senior housing organizations through the cloud, providing them with imaging diagnostic services for central nervous system diseases.

Meinian Onehealth

Meinian Onehealth Healthcare (Group) Co., Ltd has established more than 600 professional physical exam centers nationwide and is China’s leading enterprise in the physical exam industry. Dr. Brain and Meinian Onehealth have jointly launched a series of products and offerings, such as AI-based accurate whole brain testing and brain disease prevention, to provide convenient, accurate and efficient brain health screening services for the public and help fulfil the Healthy China strategy.

Changcheng Property Group—Co-Housing

Dr. Brain has entered into a comprehensive strategic cooperation with Changcheng Property Co-Housing to establish an intelligent cognitive testing and training center. Both parties will fully combine the advantages in their respective fields, integrate top international resources, employ cutting-edge technologies in brain science, medical big data, and artificial intelligence, link online and offline efforts, develop new rehabilitation training modules, build China's first intelligent early screening, prevention, and rehabilitation system for cognitive disorders, and continue to provide one-stop, full-cycle, professional, and personalized health care services for the elderly in surrounding communities, including treatment, nursing, and rehabilitation. Based on this, we strive to build an innovative and intelligent elderly endowment pattern that is truly in line with the national conditions, set a benchmark for the industry, and extend it to the whole country, benefiting more families.